Clinical implications of arrest-defective protein 1 expression in hepatocellular carcinoma: A novel predictor of microvascular invasion

Digestive Diseases

Volumn 30, Issue 6, 2012, Pages 603-608

  Shim, Ju Hyun ^a   Chung, Young Hwa ^a   Kim, Jeong A ^a   Lee, Danbi ^a   Kim, Kang Mo ^a   Lim, Young Suk ^a   Lee, Han Chu ^a   Lee, Yung Sang ^a   Yu, Eunsil ^a   Lee, Young Joo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Arrest defective protein 1; Hepatocellular carcinoma; Liver resection; Microvascular invasion

Indexed keywords

ARREST DEFECTIVE PROTEIN 1; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TISSUE LEVEL; VASCULAR TUMOR;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; N-TERMINAL ACETYLTRANSFERASE A; N-TERMINAL ACETYLTRANSFERASE E; NEOPLASM INVASIVENESS; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84871828591     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000343090     Document Type: Conference Paper

References (22)

1. Bosch FX, Ribes J, Diaz M, Cleries R: Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004; 127(suppl 1): S5-S16. (Pubitemid 39423365)
2. El-Serag HB, Rudolph KL: Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576. (Pubitemid 46890874)
3. Kim DY, Han KH: Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer 2012;1: 2-14.
4. Valfre di Bonzo L, Novo E, Cannito S, Busletta C, Paternostro C, Povero D, Parola M: Angiogenesis and liver fibrogenesis. Histol Histopathol 2009;24: 1323-1341.
5. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364. (Pubitemid 26272076)
6. Kim KR, Moon HE, Kim KW: Hypoxia-induced angiogenesis in human hepatocellular carcinoma. J Mol Med (Berl) 2002; 80: 703-714.
7. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257.
8. Hockel M, Vaupel P: Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001; 93: 266-276. (Pubitemid 32219813)
9. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005; 105: 659-669. (Pubitemid 40070750)
10. Polevoda B, Sherman F: N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J Mol Biol 2003; 325: 595-622. (Pubitemid 36268685)
11. Kuo HP, Hung MC: Arrest-defective-1 protein (ARD1): Tumor suppressor or oncoprotein? Am J Transl Res 2010; 2: 56-64.
12. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, Yoo MA, Song EJ, Lee KJ, Kim KW: Regulation and destabilization of HIF-1 by ARD1-mediated acetylation. Cell 2002; 111: 709-720. (Pubitemid 35441252)
13. Bilton R, Mazure N, Trottier E, Hattab M, Dery MA, Richard DE, Pouyssegur J, Brahimi-Horn MC: Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor-1 and is not induced by hypoxia or HIF. J Biol Chem 2005; 280: 31132-31140. (Pubitemid 41291849)
14. Brahimi-Horn C, Mazure N, Pouyssegur J: Signalling via the hypoxia-inducible factor-1 requires multiple posttranslational modifications. Cell Signal 2005; 17: 1-9. (Pubitemid 39286774)
15. Yu M, Gong J, Ma M, Yang H, Lai J, Wu H, Li L, Tan D: Immunohistochemical analysis of human arrest-defective-1 expressed in cancers in vivo. Oncol Rep 2009; 21: 909-915.
16. Arnesen T, Thompson PR, Varhaug JE, Lillehaug JR: The protein acetyltransferase ARD1: A novel cancer drug target? Curr Cancer Drug Targets 2008; 8: 545-553.
17. Jiang B, Ren T, Dong B, Qu L, Jin G, Li J, Qu H, Meng L, Liu C, Wu J, et al: Peptide mimic isolated by autoantibody reveals human arrest-defective 1 overexpression is associated with poor prognosis for colon cancer patients. Am J Pathol 2010; 177: 1095-1103.
18. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 Y CT method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
19. Kalvik TV, Arnesen T: Protein N-terminal acetyltransferases in cancer. Oncogene 2012, in press
20. Bruix J, Sherman M: Management of hepatocellular carcinoma: An update. Hepatology 2011; 53: 1020-1022.
21. Kuo HP, Lee DF, Chen CT, Liu M, Chou CK, Lee HJ, Du Y, Xie X, Wei Y, Xia W, et al: ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal 2010; 3:ra9.
22. Midorikawa Y, Tsutsumi S, Taniguchi H, Ishii M, Kobune Y, Kodama T, Makuuchi M, Aburatani H: Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis. Jpn J Cancer Res 2002; 93: 636-643. (Pubitemid 34851230)